Objective: The adenosinergic system may influence excitability in the brain. Endogenous and exogenous adenosine has anticonvulsant activity presumably by activating A1 receptors. Adenosine A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA) may thus bolster anticonvulsant effects, but its action and the number of A1 receptors at different developmental stages are not known. Methods: Hippocampal epileptic afterdischarges (ADs) were elicited in 12-, 15-, 18-, 25-, 45-, and 60-day-old rats. Stimulation and recording electrodes were implanted into the dorsal hippocampus. The A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (CCPA, 0.5 or 1 mg/kg) was administered intraperitoneally 10 min before the first stimulation. Control animals were injected with saline. All rats were stimulated with a 2-s series of 1-ms biphasic pulses delivered at 60 Hz with increasing stepwise intensity (0.05-0.6 mA). Each age and dose group contained 9-14 animals. The AD thresholds and durations were evaluated, and the A1 receptors were detected in the hippocampus in 7-, 10-, 12-, 15-, 18-, 21-, 25-, 32-, and 52-day-old rats. Results: Both CCPA doses significantly increased hippocampal AD thresholds in 12-, 15-, 18-, and 60-day-old rats compared to controls. In contrast, the higher dose significantly decreased AD threshold in the 25-day-old rats. The AD durations were significantly shortened in all age groups except for 25-day-old rats where they were significantly prolonged. A1 receptor expression in the hippocampus was highest in 10-day-old rats and subsequently decreased. Significance: The adenosine A1 receptor agonist CCPA exhibited anticonvulsant activity at all developmental stages studied here except for 25-day-old rats. Age-related differences might be due to the development of presynaptic A1 receptors in the hippocampus.

Department of Developmental Epileptology Institute of Physiology Czech Academy of Sciences Prague Czechia

Department of Neurology 2nd Faculty of Medicine Motol University Hospital Charles University Prague Czechia

Department of Neurosciences Biomedicine and Movement Sciences University of Verona Verona Italy

National Institute of Mental Health Klecany Czechia

Zobrazit více v PubMed

Abdelmalik P. A., Burnham W. M., Carlen P. L. (2005). Increased seizure susceptibility of the hippocampus compared with the neocortex of the immature mouse brain in vitro. Epilepsia 46 (3), 356–366. 10.1111/j.0013-9580.2005.34204.x PubMed DOI

Aicardi J., Shorvon S. D., (1997). “Intractable epilepsy,” in Epilepsy: a comprehensive textbook. Eds. Engel J., Pedley T. A. (Philadelphia: Lippincott-Raven; ), 1325–1331.

Arosio B., Casati M., Gussago C., Ferri E., Abbate C., Scortichini V., et al. (2016). Adenosine Type A2A receptor in peripheral cell from patients with Alzheimer’s disease, vascular dementia, and idiopathic normal pressure hydrocephalus: a new/old potential target. J. Alzheimers Dis. 54 (2), 417–425. 10.3233/JAD-160324 PubMed DOI

Ault B., Wang C. M. (1986). Adenosine inhibits epileptiform activity arising in hippocampal area CA3. Br. J. Pharmacol. 87 (4), 695–703. 10.1111/j.1476-5381.1986.tb14587.x PubMed DOI PMC

Barrie A. P., Nicholls D. G. (1993). Adenosine A1 receptor inhibition of glutamate exocytosis and protein kinase C–mediated decoupling. J. Neurochem. 60, 1081–1086. 10.1111/j.1471-4159.1993.tb03257.x PubMed DOI

Bier D., Holschbach M. H., Wutz W., Olsson R. A., Coenen H. H. (2006). Metabolism of A(1)1 adenosine receptor positron tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans. Drug Metab. Dispos. 34 (4), 570–576. 10.1124/dmd.105.006411 PubMed DOI

Boison D. (2005). Adenosine and epilepsy: from therapeutic rationale to new antiepileptic strategies. Neuroscientist 11 (1), 25–36. 10.1177/1073858404269112 PubMed DOI

Boison D., Aronica E. (2015). Comorbidities in neurology: is adenosine the common link? Neuropharmacology 97, 18–34. 10.1016/j.neuropharm.2015.04.031 PubMed DOI PMC

Bragin A., Penttonen M., Buzsáki G. (1997). Termination of epileptic afterdischarge in the hippocampus. J. Neurosci. 17 (7), 2567–2579. 10.1523/JNEUROSCI.17-07-02567.1997 PubMed DOI PMC

Camm A. J., Garratt C. J. (1991). Adenosine and supraventrivular tachycardia. N. Engl. J. Med. 325, 1621–1629. 10.1056/NEJM199112053252306 PubMed DOI

Cechova S., Elsobky A. M., Venton B. J. (2010). A1 receptors self-regulate adenosine release in the striatum: evidence of autoreceptor characteristics. Neuroscience 171 (4), 1006–1015. 10.1016/j.neuroscience.2010.09.063 PubMed DOI PMC

Clark A. N., Youkey R., Liu X., Jia L., Blatt R., Day Y. J., et al. (2007). A1 adenosine receptor activation promotes angiogenesis and release of VEGF from monocytes. Circ. Res. 101 (11), 1130–1138. 10.1161/CIRCRESAHA.107.150110 PubMed DOI

Colella A. D., Chegenii N., Tea M. N., Gibbins I. L., Williams K. A., Chataway T. K. (2012). Comparison of stain-free gels with traditional immunoblot loading control methodology. Anal. Biochem. 430, 108–110. 10.1016/j.ab.2012.08.015 PubMed DOI

Cornford E. M., Oldendorf W. H. (1975). Independent blood-brain barrier transport systems for nucleic acid precursors. Biochim. Biophys. Acta 394, 211–219. 10.1016/0005-2736(75)90259-X PubMed DOI

Costenla A. R., Diógenes M. J., Canas P. M., Rodrigues R. J., Nogueira C., Maroco J., et al. (2011). Enhanced role of adenosine A(2A) receptors in the modulation of LTP in the rat hippocampus upon ageing. Eur. J. Neurosci. 34 (1), 12–21. 10.1111/j.1460-9568.2011.07719.x PubMed DOI

Cunha R. A., Ribeiro J. A. (2000). Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals. Neuropharmacology 39 (7), 1156–1167. 10.1016/S0028-3908(99)00237-3 PubMed DOI

Cunha R. A., Constantino M. C., Sebastião A. M., Ribeiro J. A. (1995). Modification of A1 and A2a adenosine receptor binding in aged striatum, hippocampus and cortex of the rat. Neuroreport 6, 1583–1588. 10.1097/00001756-199507310-00029 PubMed DOI

Cunha R. A., Johansson B., Constantino M. D., Sebastiao A. M., Fredholm B. B. (1996). Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3 H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors. Naunyn Schmiedebergs Arch. Pharmacol. 353, 261–271. 10.1007/BF00168627 PubMed DOI

Cunha R. A., Milusheva E., Vizi E. S. (1994). Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H] acetylcholine release from different areas of the rat hippocampus. J. Neurochem. 63 (1), 207–214. 10.1046/j.1471-4159.1994.63010207.x PubMed DOI

Daval J., Werck M. (1991). Autoradiographic changes in brain adenosine A1 receptors and their coupling to G proteins following seizures in the developing rat. Brain Res. Dev. Brain Res. 59 (2), 237–247. 10.1016/0165-3806(91)90104-Q PubMed DOI

Daval J. L., Werck M. C., Nehlig A., Pereira de Vasconcelos A. (1991). Quantitative autoradiographic study of the postnatal development of adenosine A1 receptors and their coupling to G proteins in the rat brain. Neuroscience 40 (3), 841–851. 10.1016/0306-4522(91)90016-H PubMed DOI

Descombes S., Avoli M., Psarropoulou C. (1998). A comparison of the adenosine-mediated synaptic inhibition in the CA3 area of immature and adult rat hippocampus. Brain Res. Dev. Brain Res. 110 (1), 51–59. 10.1016/S0165-3806(98)00093-5 PubMed DOI

Doriat J. F., Humbert A. C., Daval J. L. (1996). Brain maturation of high-affinity adenosine A2 receptors and their coupling to G-proteins. Brain Res. Dev. Brain Res. 93 (1–2), 1–9. 10.1016/0165-3806(96)00009-0 PubMed DOI

Dunwiddie T. V., Masino S. A. (2001). The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24, 31–55. 10.1146/annurev.neuro.24.1.31 PubMed DOI

Ekonomou A., Sperk G., Kostopoulos G., Angelatou F. (2000). Reduction of A1 adenosine receptors in rat hippocampus after kainic acid–induced limbic seizures. Neurosci. Lett. 284, 49–52. 10.1016/S0304-3940(00)00954-X PubMed DOI

Fastbom J., Fredholm B. B. (1985). Inhibition of [3H] glutamate release from rat hippocampal slices by L-phenylisopropyladenosine. Acta Physiol. Scand. 125 (1), 121–123. 10.1111/j.1748-1716.1985.tb07698.x PubMed DOI

Frush D. P., McNamara J. O. (1986). Evidence implicating dentate granule cells in wet dog shakes produced by kindling stimulations of entorhinal cortex. Exp. Neurol. 92, 102–113. 10.1016/0014-4886(86)90128-7 PubMed DOI

Fumagalli M., Lecca D., Abbracchio M. P., Ceruti S. (2017). Pathophysiological role of purines and pyrimidines in neurodevelopment: unveiling new pharmacological approaches to congenital brain diseases. Front. Pharmacol. 19 (8), 941. 10.3389/fphar.2017.00941 PubMed DOI PMC

Geiger J. D., LaBella F. S., Nagy J. I. (1984). Ontogenesis of adenosine receptors in the central nervous system of the rat. Brain Res. 315 (1), 97–104. 10.1016/0165-3806(84)90080-4 PubMed DOI

Gorter J. A., van Vliet E. A., Lopes da Silva F. H. (2016). Which insights have we gained from the kindling and post-status epilepticus models? J. Neurosci. Methods 260, 96–108. 10.1016/j.jneumeth.2015.03.025 PubMed DOI

Greene R. W., Haas H. L. (1991). The electrophysiology of adenosine in the mammalian central nervous system. Prog. Neurobiol. 36 (4), 329–341. 10.1016/0301-0082(91)90005-L PubMed DOI

Huber A., Güttinger M., Möhler H., Boison D. (2002). Seizure suppression by adenosine A(2A) receptor activation in a rat model of audiogenic brainstem epilepsy. Neurosci. Lett. 329 (3), 289–292. 10.1016/S0304-3940(02)00684-5 PubMed DOI

Huber A., Padrun V., Déglon N., Aebischer P., Möhler H., Boison D. (2001). Grafts of adenosine-releasing cells suppress seizures in kindling epilepsy. Proc. Natl. Acad. Sci. U. S. A. 98, 7611–7616. 10.1073/pnas.131102898 PubMed DOI PMC

Ipata P. L. (2011). Origin, utilization, and recycling of nucleosides in central nervous system. Adv. Physiol. Educ. 35 (4), 342–346. 10.1152/advan.00068.2011 PubMed DOI

Isomura Y., Sugimoto M., Fujiwara-Tsukamoto Y., Yamamoto-Muraki S., Yamada J., Fukuda A. (2003). Synaptically activated Cl- accumulation responsible for depolarizing GABAergic responses in mature hippocampal neurons. J. Neurophysiol. 90, 2752–2756. 10.1152/jn.00142.2003 PubMed DOI

Janusz C. A., Berman R. F. (1993). The adenosine binding enhancer, PD 81,723, inhibits epileptiform bursting in the hippocampal brain slice. Brain Res. 619 (1–2), 131–136. 10.1016/0006-8993(93)91604-Q PubMed DOI

Jin Z. L., Lee T. F., Zhou S. J., Wang L. C. (1993). Age-dependent change in the inhibitory effect of an adenosine agonist on hippocampal acetylcholine release in rats. Brain Res. Bull. 30 (1–2), 149–152. 10.1016/0361-9230(93)90051-C PubMed DOI

Johansson B., Georgiev V., Fredholm B. B. (1997). Distribution and postnatal ontogeny of adenosine A2A receptors in rat brain: comparison with dopamine receptors. Neuroscience 80, 1187–1207. 10.1016/S0306-4522(97)00143-7 PubMed DOI

Johnston M. V. (2004). “Seizures in childhood,” in Nelson textbook of pediatrics, 17th Ed. Eds. Behrman R. E., Kliegman R. M., Jenson H. B. (Philadelphia: Saunders; ), 2013–2038.

Kandratavicius L., Balista P. A., Lopes-Aguiar C., Ruggiero R. N., Umeoka E. H., Garcia-Cairasco N., et al. (2014). Animal models of epilepsy: use and limitations. Neuropsychiat. Dis. Treat. 10, 1693–1705. 10.2147/NDT.S50371 PubMed DOI PMC

Klaasse E. C., Ijzerman A. P., de Grip W. J., Beukers M. W. (2008). Internalization and desensitization of adenosine receptors. Purinergic. Signal. 4 (1), 21–37. 10.1007/s11302-007-9086-7 PubMed DOI PMC

Klishin A., Lozovaya N., Krishtal O. (1995). A1 adenosine receptors differentially regulate the N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated components of hippocampal excitatory postsynaptic current in a Ca2+/Mg(2+)-dependent manner. Neuroscience 65 (4), 947–953. 10.1016/0306-4522(94)00518-A PubMed DOI

Klitgaard H., Knutsen L. J., Thomsen C. (1993). Contrasting effects of adenosine A1 and A2 receptor ligands in different chemoconvulsive rodent models. Eur. J. Pharmacol. 242 (3), 221–228. 10.1016/0014-2999(93)90245-D PubMed DOI

Klotz K. N., Lohse M. J., Schwabe U., Cristalli G., Vittori S., Grifantini M. (1989). 2-Chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA)—a high affinity agonist radioligand for A1 adenosine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 340 (6), 679–683. 10.1007/BF00717744 PubMed DOI

Kotloski R., Lynch M., Lauersdorf S., Sutula T. (2002). Repeated brief seizures induce progressive hippocampal neuron loss and memory deficits. Prog. Brain Res. 135, 95–110. 10.1016/S0079-6123(02)35010-6 PubMed DOI

Layland J., Carrick D., Lee M., Oldroyd K., Berry C. (2014). Adenosine: physiology, pharmacology, and clinical applications. JACC Cardiovasc Interv. 7 (6), 581–591. 10.1016/j.jcin.2014.02.009 PubMed DOI

Lewin E., Bleck V. (1981). Electroshock seizures in mice: effect on brain adenosine and its metabolites. Epilepsia 22, 577–581. 10.1111/j.1528-1157.1981.tb04129.x PubMed DOI

Lopes L. V., Cunha R. A., Ribeiro J. A. (1999). Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. J. Neurophysiol. 82, 3196–3203. 10.1152/jn.1999.82.6.3196 PubMed DOI

Lopes L. V., Rebola N., Costenla A. R., Halldner L., Jacobson M., Oliveira C. R., et al. (2003). Adenosine A3 receptors in the rat hippocampus: lack of interaction with A1 receptors. Drug Dev. Res. 58, 428–438. 10.1002/ddr.10188 DOI

Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265–275. PubMed

Marangos P. J., Patel J., Stivers J. (1982). Ontogeny of adenosine binding sites in rat forebrain and cerebellum. J. Neurochem. 39 (1), 267–270. 10.1111/j.1471-4159.1982.tb04732.x PubMed DOI

Mares P. (2014). A1 not A2A adenosine receptors play a role in cortical epileptic afterdischarges in immature rats. J. Neural Transm. 121 (11), 1329–1336. 10.1007/s00702-014-1234-y PubMed DOI

Mathot R. A. A., Appel S., van Schaick E. A., Soudijn W., Ijzerman A. P., Danhof M. (1993). High-performance liquid chromatography of the adenosine A1 agonist N6-cyclopentyladenosine and the A1 antagonist 8-cyclopentyltheophylline and its application in a pharmacokinetic study in rats. J. Chromatogr. 620, 113–120. 10.1016/0378-4347(93)80058-C PubMed DOI

Mills J. H., Alabanza L., Weksler B. B., Couraud P. O., Romero I. A., Bynoe M. S. (2011). Human brain endothelial cells are responsive to adenosine receptor activation. Purinergic. Signalling 7 (2), 265–273. 10.1007/s11302-011-9222-2 PubMed DOI PMC

Moshe S. L. (2010). Seizures early in life. Neurology 55, 15–20. PubMed

Ogunshola O. O., Stewart W. B., Mihalcik V., Solli T., Madri J. A., and Ment, L R. (2000). Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Brain Res. Dev. Brain Res. 119 (1), 139–153. 10.1016/S0165-3806(99)00125-X PubMed DOI

Pagonopoulou O., Angelatou F. (1992). Reduction of A1 adenosine receptors in cortex, hippocampus and cerebellum in ageing mouse brain. Neuroreport 3, 735–737. 10.1097/00001756-199209000-00003 PubMed DOI

Pavan B., Ijzerman A. P. (1998). Processing of adenosine receptor agonists in rat and human whole blood. Biochem. Pharamacol. 56 (12), 1625–32. 10.1016/S0006-2952(98)00270-6 PubMed DOI

Peterson G. L. (1997). A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346–356. 10.1016/0003-2697(77)90043-4 PubMed DOI

Pometlova M., Kubova H., Mares P. (2010). Effects of 2-chloroadenosine on cortical epileptic afterdischarges in immature rats. Pharmacol. Rep. 62, 62–67. 10.1016/S1734-1140(10)70243-7 PubMed DOI

Rebola N., Coelho J. E., Costenla A. R., Lopes L. V., Parada A., Oliveira C. R., et al. (2003. b). Decrease of adenosine A1 receptor density and of adenosine neuromodulation in the hippocampus of kindled rats. Eur. J. Neurosci. 18, 820–828. 10.1046/j.1460-9568.2003.02815.x PubMed DOI

Rebola N., Rodrigues R. J., Lopes L. V., Richardson P. J., Oliveira C. R., Cunha R. A. (2005). Adenosine A1 and A2A receptors are co-expressed in pyramidal neurons and co-localized in glutamatergic nerve terminals of the rat hippocampus. Neuroscience 133 (1), 79–83. 10.1016/j.neuroscience.2005.01.054 PubMed DOI

Rebola N., Sebastião A. M., de Mendonca A., Oliveira C. R., Ribeiro J. A., Cunha R. A. (2003. a). Enhanced adenosine A2A receptor facilitation of synaptic transmission in the hippocampus of aged rats. J. Neurophysiol. 90 (2), 1295–1303. 10.1152/jn.00896.2002 PubMed DOI

Ribeiro F. F., Xapelli S., Miranda-Lourenço C., Tanqueiro S. R., Fonseca-Gomes J., Diógenes M. J., et al. (2016). Purine nucleosides in neuroregeneration and neuroprotection. Neuropharmacology 104, 226–242. 10.1016/j.neuropharm.2015.11.006 PubMed DOI

Rivkees S. A. (1995). The ontogeny of cardiac and neural A1 adenosine receptor expression in rats. Brain Res. Dev. Brain Res. 89 (2), 202–213. 10.1016/0165-3806(95)00120-3 PubMed DOI

Rivkees S. A., Price S. L., Zhou F. C. (1995). Immunohistochemical detection of A1 adenosine receptors in rat brain with emphasis on localization in the hippocampal formation, cerebral cortex, cerebellum, and basal ganglia. Brain Res. 677 (2), 193–203. 10.1016/0006-8993(95)00062-U PubMed DOI

Sanchez R. M., Jensen F. (2001). Maturational aspects of epilepsy mechanisms and consequences for the immature brain. Epilepsia 42 (5), 577–585. 10.1046/j.1528-1157.2001.12000.x PubMed DOI

Schultz V., Lowenstein J. M. (1978). The purine nucleotide cycle. J. Biol. Chem. 253, 1938–1943. PubMed

Simonato M., Varani K., Muzzolini A., Bianchi C., Beani L., Borea P. A. (1994). Adenosine A1 receptors in the rat brain in the kindling model of epilepsy. Eur. J. Pharmacol. 265 (3), 121–124. 10.1016/0014-2999(94)90421-9 PubMed DOI

Sollevi A. (1997). Adenosine for pain control. Acta. Anaesthesiol. Scand. Suppl. 110, 135–136. 10.1111/j.1399-6576.1997.tb05532.x PubMed DOI

Tancredi V., D’Antuono M., Nehlig A., Avoli M. (1998). Modulation of epileptiform activity by adenosine A1 receptor-mediated mechanisms in the juvenile rat hippocampus. J. Pharmacol. Exp. Ther. 286 (3), 1412–1419. PubMed

Taylor C. P., Dudek F. E. (1982). Synchronous neural afterdischarges in rat hippocampal slices without active chemical synapses. Science 218 (4574), 810–812. 10.1126/science.7134978 PubMed DOI

Veliskova J., Velisek L., Mares P. (1988). Epileptic phenomena produced by kainic acid in laboratory rats during ontogenesis. Physiol. Bohemoslov. 37 (5), 395–405. PubMed

Viitanen T., Ruusuvuori E., Kaila K., Voipio J. (2010). The K+-Cl cotransporter KCC2 promotes GABAergic excitation in the mature rat hippocampus. J. Physiol. 588, 1527–1540. 10.1113/jphysiol.2009.181826 PubMed DOI PMC

Wieraszko A., Seyfried T. N. (1989). Increased amount of extracellular ATP in stimulated hippocampal slices of seizure prone mice. Neurosci. Lett. 106, 287–293. 10.1016/0304-3940(89)90178-X PubMed DOI

Wojcik W. J., Neff N. H. (1983). Differential location of adenosine A1 and A2 receptors in striatum. Neurosci. Lett. 41 (1–2), 55–60. 10.1016/0304-3940(83)90222-7 PubMed DOI

Zavala-Tecuapetla C., Kubova H., Otahal J., Tsenov G., Mares P. (2014). Age-dependent suppression of hippocampal epileptic afterdischarges by metabotropic glutamate receptor 5 antagonist MTEP. Pharmacol. Rep. 66, 927–930. 10.1016/j.pharep.2014.02.018 PubMed DOI

Zhou Q. Y., Li C., Olah M. E. (1992). Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc. Natl. Acad. Sci. U. S. A. 89 (16), 7432–7437. 10.1073/pnas.89.16.7432 PubMed DOI PMC

Seizures elicited by transcorneal 6 Hz stimulation in developing rats

Epilepsy Research in the Institute of Physiology of the Czech Academy of Sciences in Prague